Hydrazine

Hydrazine

SCHEMBL9545541

CC(=O)NC(CCS)C(=O)O.NN

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.64
KDM4E B2RXH2 1/20 0.64
MAPT P10636 1/20 0.64
THRB P10828 1/20 0.64
ALOX15 P16050 1/20 0.64
NFKB1 P19838 1/20 0.64
PTGS2 P35354 1/20 0.64
THPO P40225 1/20 0.64
RECQL P46063 1/20 0.64
BLM P54132 1/20 0.64
ALDH1A1 P00352 1/20 0.52
GNPAT O15228 2/20 0.47
FOLH1 Q04609 5/20 0.42
ACE P12821 1/20 0.40
RIMKLA Q8IXN7 1/20 0.39
NAALAD2 Q9Y3Q0 1/20 0.39
TGFBR1 P36897 1/20 0.36
ITGB3 P05106 1/20 0.35
ITGA2B P08514 1/20 0.35
ANPEP P15144 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL93990 0.96 SMN1; SMN2 (0.69) SMN1; SMN2KDM4EMAPTTHRBALOX15
SCHEMBL93989 0.96 SMN1; SMN2 (0.69) SMN1; SMN2KDM4EMAPTTHRBALOX15
SCHEMBL93988 0.96 SMN1; SMN2 (0.69) SMN1; SMN2KDM4EMAPTTHRBALOX15
SCHEMBL27496141 0.90 SMN1; SMN2 (0.62) SMN1; SMN2KDM4EMAPTTHRBALOX15
SCHEMBL931029 0.85 KDM4E (0.67) SMN1; SMN2KDM4EMAPTTHRBALOX15
SCHEMBL12729510 0.84 SMN1; SMN2 (0.64) SMN1; SMN2KDM4EMAPTTHRBALOX15
SCHEMBL25509507 0.84 SMN1; SMN2 (0.64) SMN1; SMN2KDM4EMAPTTHRBALOX15
Acetylcysteine SCHEMBL27610444 0.83 MAPT (0.91) SMN1; SMN2KDM4EMAPTTHRBALOX15
SCHEMBL3027984 0.82 SMN1; SMN2 (0.62) SMN1; SMN2KDM4EMAPTTHRBALOX15
SCHEMBL10070143 0.82 KDM4E (0.50) SMN1; SMN2KDM4EMAPTTHRBALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1993023425-A1 METAL CHELATING PEPTIDE THE ONTARIO CANCER INSTITUTE (CA) 1993-11-25 WO disclosed